176 related articles for article (PubMed ID: 38182570)
1. Protein tyrosine phosphatase PTPRO represses lung adenocarcinoma progression by inducing mitochondria-dependent apoptosis and restraining tumor metastasis.
Dai Y; Shi S; Liu H; Zhou H; Ding W; Liu C; Jin L; Xie W; Kong H; Zhang Q
Cell Death Dis; 2024 Jan; 15(1):11. PubMed ID: 38182570
[TBL] [Abstract][Full Text] [Related]
2. Comprehensively Analyze the Prognosis Significance and Immune Implication of PTPRO in Lung Adenocarcinoma.
Lin Z; Zhang J; Liu B; Hong Z; Chen Z; Huang X
Mediators Inflamm; 2023; 2023():5248897. PubMed ID: 36816740
[TBL] [Abstract][Full Text] [Related]
3. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3.
Hou J; Xu J; Jiang R; Wang Y; Chen C; Deng L; Huang X; Wang X; Sun B
Hepatology; 2013 Feb; 57(2):678-88. PubMed ID: 22821478
[TBL] [Abstract][Full Text] [Related]
5. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Suppression Mechanisms of Protein Tyrosine Phosphatase O and Clinical Applications.
Kang MM; Shan SL; Wen XY; Shan HS; Wang ZJ
Asian Pac J Cancer Prev; 2015; 16(15):6215-23. PubMed ID: 26434819
[TBL] [Abstract][Full Text] [Related]
7. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
[TBL] [Abstract][Full Text] [Related]
8. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
9. miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.
Wang J; Yao S; Diao Y; Geng Y; Bi Y; Liu G
Thorac Cancer; 2020 Jun; 11(6):1396-1405. PubMed ID: 32220063
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543.
Xu Y; Lin L; Lv D; Yan S; He S; Ge H
Tissue Cell; 2021 Oct; 72():101535. PubMed ID: 33892399
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma.
Xue F; Jia Y; Zhao J
Surg Oncol; 2020 Jun; 33():108-117. PubMed ID: 32561075
[TBL] [Abstract][Full Text] [Related]
13. STRIP2, a member of the striatin-interacting phosphatase and kinase complex, is implicated in lung adenocarcinoma cell growth and migration.
Qiu LM; Sun YH; Chen TT; Chen JJ; Ma HT
FEBS Open Bio; 2020 Mar; 10(3):351-361. PubMed ID: 31901223
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase receptor type O (Ptpro) regulates cerebellar formation during zebrafish development through modulating Fgf signaling.
Liao WH; Cheng CH; Hung KS; Chiu WT; Chen GD; Hwang PP; Hwang SP; Kuan YS; Huang CJ
Cell Mol Life Sci; 2013 Jul; 70(13):2367-81. PubMed ID: 23361036
[TBL] [Abstract][Full Text] [Related]
15. Protein Tyrosine Phosphatase Receptor Type J (PTPRJ) Regulates Retinal Axonal Projections by Inhibiting Eph and Abl Kinases in Mice.
Yu Y; Shintani T; Takeuchi Y; Shirasawa T; Noda M
J Neurosci; 2018 Sep; 38(39):8345-8363. PubMed ID: 30082414
[TBL] [Abstract][Full Text] [Related]
16. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma.
Chen L; Wu Q; Xu X; Yang C; You J; Chen F; Zeng Y
Exp Cell Res; 2021 Jan; 398(2):112414. PubMed ID: 33301764
[TBL] [Abstract][Full Text] [Related]
17. CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinoma.
Chen Y; Tang J; Lu T; Liu F
Thorac Cancer; 2020 Jul; 11(7):1848-1860. PubMed ID: 32395869
[TBL] [Abstract][Full Text] [Related]
18. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
Chen A; Ding S; Shen X; Lin X
Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
Wan S; Liu Z; Chen Y; Mai Z; Jiang M; Di Q; Sun B
Bioengineered; 2021 Dec; 12(2):11959-11977. PubMed ID: 34818974
[TBL] [Abstract][Full Text] [Related]
20. Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.
Ming F; Sun Q
Mol Med Rep; 2017 Jul; 16(1):746-754. PubMed ID: 28586036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
